Conotte, S., Tassin, A., Delpierre, A., Zouaoui Boudjeltia, K., & Legrand, A. (31 January 2020). Contribution of oxidative stress to muscle dysfunction associated to chronic intermittent hypoxia : an interventional study in a murine model [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Processes and Antioxidants, Mons, Belgium. |
  | Pierard, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (11 December 2018). Effect of hypoxia on adiponectin pathway in murine and cellular models: which involvement in COPD-associated cardiovascular risk ? [Poster presentation]. Europhysiology, London, United Kingdom.  Editorial reviewed |
  | Carlier, S., Saussez, J., Scalia, A., Chodzynski, K., Nishio, S., Thayse, K., Brunner, P., Zouaoui Boudjeltia, K., & Coussement, G. (10 March 2018). IN VIVO, IN VITRO AND IN SILICO COMPARISON OF TWO DEVICES TO MEASURE FRACTIONAL FLOW RESERVE [Paper presentation]. AMERICAN COLLEGE OF CARDIOLOGY, Orlando, United States - Florida. |
 | Soubhye, J., Chikh Alard, I., Aldib, I., Prévost, M., Gelbcke, M., De Carvalho, A.-L., Furtmuller, P. G., Obinger, C., Flemming, J., Tadrent, S., Meyer, F., Rousseau, A., Nève, J., Mathieu, V., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (03 July 2017). Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors using Virtual Screening Procedure. Journal of Medicinal Chemistry, 60 (15), 6563-6586. Peer Reviewed verified by ORBi |
 | Soubhye, J., Gelbcke, M., Van Antwerpen, P., Dufrasne, F., Boufadi, Y., Nève, J., Furtmuller, P. G., Obinger, C., Zouaoui Boudjeltia, K., & Meyer, F. (02 December 2016). From dynamic combinatorial chemistry to in vivo evaluation of reversible and irreversible myeloperoxidase inhibitors. ACS Medicinal Chemistry Letters, 8 (2), 206-210. Peer reviewed |
 | Pierard, M., Conotte, S., Tassin, A., Boutry, S., Uzureau, P., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice. Nutrition and Metabolism. doi:10.1186/s12986-016-0138-2 Peer Reviewed verified by ORBi |
Aldib, I., Gelbcke, M., Soubhye, J., Prévost, M., Furtmuller, P. G., Obinger, C., Elfving, B., Chikh Alard, I., Roos, G., Delporte, C., Berger, G., Dufour, D., Zouaoui Boudjeltia, K., Nève, J., Dufrasne, F., & Van Antwerpen, P. (10 November 2016). Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study. European Journal of Medicinal Chemistry, 123, 746-762. Peer Reviewed verified by ORBi |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (30 June 2016). Modulations of adiponectin pathway inuced by hypoxia in murine and cellular models [Poster presentation]. Federation of European Physiological Societies, Paris, France. Editorial reviewed |
Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Paper presentation]. Federation of European Physiological Societies, Paris, France. |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Modulations of adiponectin pathway induced by hypoxia in murin and cellular models [Paper presentation]. Federation of European Physiological Societies, Paris, France. |
 | Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (28 June 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. Federation of European Physiological Societies, Paris, France. |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (18 May 2016). Composante hypoxémique de la BPCO : quel impact sur les ADIPO-récepteurs ? [Poster presentation]. MDC 2016 Valenciennes, Valenciennes, France. |
 | Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (22 April 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. 12th meeting of the FRS-FNRS Contact Group on oxidative stress and antioxydants : New Frontiers in Oxidative Stress and Redox Regulation, Louvain-la-Neuve, Belgium. |
Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Cardiovascular alterations associated to intermittent hypoxia in a mouse model of obstructive sleep apnea (OSA) [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium. |
Pierard, M., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Effect of continuous and intermittent hypoxia on adiponectin multimeric forms and muscle receptors in mice [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium. |
Ribeiro de Sousa, D., Vallecilla, C., CHODZYNSKI, K., Corredor Jerez, R., Malaspinas, O., EKER, O. F., Ouared, R., Vanhamme, L., Legrand, A., Chopard, B., Courbebaisse, G., & Zouaoui Boudjeltia, K. (27 July 2015). Determination of a shear rate threshold for thrombus formation in intracranial aneurysms. Journal of NeuroInterventional Surgery, 0, 1-6. doi:10.1136/neurintsurg-2015-011737 Peer Reviewed verified by ORBi |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (12 May 2015). Effet de l'exercice physique sur l'adiponectine dans un modèle murin de syndrome métabolique [Poster presentation]. Journée scientifique du Pôle hainuyer (JSPH1), Mons, Belgium. |
Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (10 March 2015). Pathophysiological effects of a well-controlled exposure to intermittent hypoxia in mice : validation of a sleep apnea model [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Pahulycz, L., Tassin, A., Conotte, S., Zouaoui Boudjeltia, K., Piagnerelli, M., & Legrand, A. (10 March 2015). Impact of hyperoxia in a murine model of intensive care unit myopathy [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Pahulycz, L., Piagnerelli, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (23 January 2015). Impact de l'hyperoxie sur la myopathie dans un modèle murin de sepsis [Poster presentation]. 43e Congrès International de la SRLF (Société de Réanimation de Langue Française), Paris, France. |
 | Soubhye, J., Prévost, M., Elfving, B., Gelbcke, M., Podrecca, M., Conotte, R., Colet, J.-M., Furtmuller, P. G., Delporte, C., Rousseau, A., Vanhaeverbeek, M., Nève, J., Obinger, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., & Dufrasne, F. (01 August 2014). Hybrid Molecules Inhibiting Myeloperoxidase Activity and Serotonin Reuptake: A Possible New Approach of Major Depressive Disorders with Inflammatory Syndrome. Journal of Pharmacy and Pharmacology, 66, 1122 - 133. doi:10.1111/jphp.12236 Peer Reviewed verified by ORBi |
Bensalem, S., Soubhye, J., Aldib, I., Bournine, L., Nguyen, A.-T., Vanhaeverbeek, M., Rousseau, A., Zouaoui Boudjeltia, K., Sarakbi, A., Kauffmann, J.-M., Nève, J., Prévost, M., Stévigny, C., Maiza-Benabdesselam, F., Bedjou, F., Van Antwerpen, P., & Duez, P. (16 April 2014). Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). Journal of Ethnopharmacology, 154 (2), 361-369. doi:10.1016/j.jep.2014.03.070 Peer Reviewed verified by ORBi |
Conotte, S., Colet, J.-M., Zouaoui Boudjeltia, K., & Legrand, A. (05 April 2014). Metabonomic profiling of intermittent hypoxia in a mouse model [Paper presentation]. PhysPhar Meeting, Maastricht, Netherlands. |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (05 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Paper presentation]. PhysPhar Meeting, Maastricht, Netherlands. Editorial reviewed |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (04 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Poster presentation]. PhysPhar Meeting, Maastricht, Netherlands. |
 | Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmuller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reyé, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Nève, J., Prevost, M., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (23 May 2013). Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3-Alkylindole Derivatives as Selective and Highly Potent Myeloperoxidase Inhibitors. Journal of Medicinal Chemistry, 56 (10), 3943-3958. doi:10.1021/jm4001538 Peer Reviewed verified by ORBi |
Chodzynski, K., Conotte, S., Vanhamme, L., Van Antwerpen, P., Kerkhofs, M., Legros, J. L., Vanhaeverbeek, M., Van Meerhaeghe, A., Coussement, G., Zouaoui Boudjeltia, K., & Legrand, A. (02 April 2013). A new device to mimic intermittent hypoxia in mice. PLoS ONE, 8 (4), 1-10. Peer reviewed |
 | Aldib, I., Soubhye, J., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Rousseau, A., Furtmuller, P. G., Obinger, C., Dufrasne, F., Nève, J., Van Antwerpen, P., & Prevost, M. (23 August 2012). Evaluation of New Scaffolds of Myeloperoxidase Inhibitors by Rational Design Combined with High-Throughput Virtual Screening. Journal of Medicinal Chemistry, 55 (16), 7208-7218. |
Roumeguère, T., Delrée, P., Van Antwerpen, P., Rorive, S., Vanhamme, L., De La Kethulle De Ryhove, L., serteyn, D., Wespes, E., Vanhaeverbeek, M., & Zouaoui Boudjeltia, K. (07 July 2011). Intriguing location of myeloperoxidase in the prostate: A preliminary immunohistochemical study. Prostate, 72 (5), 507-13. doi:10.1002/pros.21452 Peer Reviewed verified by ORBi |
Soubhye, J., Prevost, M., Van Antwerpen, P., Zouaoui Boudjeltia, K., Rousseau, A., Furtmuller, P. G., Obinger, C., Vanhaeverbeek, M., Ducobu, J., Nève, J., Gelbcke, M., & Dufrasne, F. (22 October 2010). Structure-Based Design, Synthesis, and Pharmacological Evaluation of 3-(Aminoalkyl)-5-fluoroindoles as Myeloperoxidase Inhibitors. Journal of Medicinal Chemistry, 53 (24). Peer Reviewed verified by ORBi |
Zouaoui Boudjeltia, K., Van Antwerpen, P., Chodzynski, K., & Coussement, G. (2010). Modélisation de l'endothélium vasculaire [Paper presentation]. VIème Symposium 'Lipides et athérosclérose', Mons, Unknown/unspecified. |
Van Antwerpen, P., Zouaoui Boudjeltia, K., Dufrasne, F., Babar, S., Moreau, P., Moguilevsky, N., Prevost, M., Vanhaeverbeek, M., Nève, J., & Ducobu, J. (2008). Tryptamine derivatives inhibit the myeloperoxidase-dependent LDL oxidation. Atherosclerosis. Supplements. Peer Reviewed verified by ORBi |
Van Antwerpen, P., Moreau, P., Zouaoui Boudjeltia, K., Babar, S., Dufrasne, F., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Nève, J. (2007). Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta. Peer Reviewed verified by ORBi |
Van Antwerpen, P., Prevost, M., Zouaoui Boudjeltia, K., Babar, S., Lessgyer, I., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Dufrasne, F. (07 November 2007). Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorganic and Medicinal Chemistry, 16 (4), 1702-1720. Peer Reviewed verified by ORBi |
Van Antwerpen, P., Zouaoui Boudjeltia, K., Dufrasne, F., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Prevost, M., Nève, J., & Ducobu, J. (12 July 2007). Inhibition of the MPO/H2O2/chloride dependent LDL oxidation assessed by in vitro, elisa and cell tests. Atherosclerosis. Supplements, 8 (1), 88-88. Peer Reviewed verified by ORBi |
Van Antwerpen, P., Dufrasne, F., Lequeux, M., Zouaoui Boudjeltia, K., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Nève, J. (12 June 2007). Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: Flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. European Journal of Pharmacology, 570 (1-3), 235-243. Peer Reviewed verified by ORBi |